Amplia Therapeutics Limited
INNMF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $42,646 | $28,288 | $33,065 | $14,921 |
| - Cash | $19,273 | $10,863 | $4,558 | $3,385 |
| + Debt | $252 | $14 | $55 | $1,587 |
| Enterprise Value | $23,625 | $17,439 | $28,562 | $13,122 |
| Revenue | $0 | $2,377 | $1,407 | $2,004 |
| % Growth | -100% | 68.9% | -29.8% | – |
| Gross Profit | -$24 | $2,237 | $1,336 | $1,674 |
| % Margin | – | 94.1% | 95% | 83.5% |
| EBITDA | -$4,473 | -$3,982 | -$2,800 | -$3,441 |
| % Margin | – | -167.5% | -199% | -171.7% |
| Net Income | -$2,761 | -$3,758 | -$2,814 | -$3,374 |
| % Margin | – | -158.1% | -200% | -168.3% |
| EPS Diluted | -0.007 | -0.01 | -0.011 | -0.017 |
| % Growth | 37.5% | 6.3% | 36.2% | – |
| Operating Cash Flow | -$5,055 | -$5,714 | -$1,172 | -$1,584 |
| Capital Expenditures | -$17 | -$2 | -$0 | -$2 |
| Free Cash Flow | -$5,072 | -$5,715 | -$1,173 | -$1,587 |